34 INOVIQ Limited Note Consolidated Group For the year ended 30 June 2022 $ For the year ended 30June 2021* $ REVENUE AND COST OF SALES FROMORDINARY ACTIVITIES Product revenue 3 276,745 468,096 Cost of sales (56,446) (64,045) GROSS PROFIT 220,299 404,051 OTHER INCOME Research and Development Tax Incentive refund 4 1,316,437 643,542 Grant income 4 404,025 317,533 Interest and miscellaneous income 4 65,668 42,882 TOTAL OTHER INCOME 1,786,130 1,003,957 OPERATING EXPENDITURES Impairment of Intangibles 10 (12,821,402) (7,321,047) General and Administration 5 (5,855,103) (4,390,832) Research and Development 5 (3,035,963) (3,415,240) Sales andMarketing 5 (548,451) (306,574) TOTAL OPERATING EXPENDITURES (22,260,919) (15,433,693) LOSS BEFORE INCOME TAX (20,254,490) (14,025,685) Income tax credit/(expense) 6 2,058,513 2,874,805 LOSS AFTER INCOME TAX (18,195,977) (11,150,880) OTHER COMPREHENSIVE INCOME Items that may be subsequently reclassified to operating result Foreign currency translation 16 (28,937) 40,076 OTHER COMPREHENSIVE GAIN/(LOSS) FOR THE YEAR, NET OF TAX (28,937) 40,076 TOTAL COMPREHENSIVE LOSS ATTRIBUTABLE TO THE MEMBERS OF INOVIQ LIMITED (18,224,914) (11,110,804) Loss per share: Cents Cents Basic loss per share 18 (20.03) (14.43) Diluted loss per share 18 (20.03) (14.43) * The group has reclassified certain expenditure items in the comparative period to be consistent with the current year classification and presentation. The accompanying notes form part of these financial statements. Consolidated Statement of Comprehensive Income for the year ended 30 June 2022
RkJQdWJsaXNoZXIy MjE2NDg3